CLRM-05 FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMACOKINETICS OF DIFFUSE MIDLINE GLIOMA USING INTRATUMORAL MICRODIALYSIS

INTRODUCTION: Diffuse midline gliomas are the most aggressive brain tumors of childhood and young adults, with documented 2 year survival rates of <10%. Treatment failure is due in part to the presence of the blood-brain barrier (BBB), which limits permeability of varied agents. Efforts to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalmage, Mahalia, Brown, Desmond, Nduom, Edjah, Jackson, Sadhana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354151/
http://dx.doi.org/10.1093/noajnl/vdac078.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354151/
http://dx.doi.org/10.1093/noajnl/vdac078.025

Ejemplares similares